Clinical trial
Study Of Alvimopan Drug For Treatment Of Constipation Due To Prescription Pain…
NCT00101998 · Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA), Industry · Completed
Key facts
| NCT number | NCT00101998 |
|---|---|
| Title | Study Of Alvimopan Drug For Treatment Of Constipation Due To Prescription Pain Medication |
| Official title | A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase IIb Study to Evaluate the Efficacy and Safety of Multiple Alvimopan Dosage Regimens for the Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects |
| Lead sponsor | Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA), Industry |
| Collaborators | GlaxoSmithKline Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Constipation, Bowel Dysfunction |
| Intervention type | Drug |
| Interventions | alvimopan, placebo |
| Enrollment | 233 |
| Start date | Oct 1, 2003 |
| Primary completion | May 1, 2006 |
| Completion | May 1, 2006 |
| First posted | Jan 19, 2005 |
| Last update posted | Aug 30, 2017 |
| Countries | Argentina, Australia, Canada, Czechia, Finland, France, Germany, Hong Kong, Hungary, India, Italy, Netherlands and 14 more |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: